HANGZHOU TIGERMEDHANGZHOU TIGERMEDHANGZHOU TIGERMED

HANGZHOU TIGERMED

No trades
See on Supercharts
Market capitalization
‪38.12 B‬CNY
‪2.02 B‬CNY
‪7.36 B‬CNY
‪486.86 M‬
Beta (1Y)
1.29

About HANGZHOU TIGERMED

CEO
Xiao Chun Cao
Headquarters
Hangzhou
Founded
2004
ISIN
CNE100001KV8
FIGI
BBG002QKZ361
Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 300347 is 51.73 CNY — it has decreased by 1.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HANGZHOU TIGERMED stocks are traded under the ticker 300347.
HANGZHOU TIGERMED is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
300347 stock is 4.48% volatile and has beta coefficient of 1.29. Check out the list of the most volatile stocks — is HANGZHOU TIGERMED there?
One year price forecast for HANGZHOU TIGERMED has a max estimate of 82.80 CNY and a min estimate of 30.08 CNY.
300347 earnings for the last quarter are 0.57 CNY whereas the estimation was 0.71 CNY which accounts for −20.20% surprise. Estimated earnings for the next quarter are 0.48 CNY. See more details about HANGZHOU TIGERMED earnings.
HANGZHOU TIGERMED revenue for the last quarter amounts to ‪1.94 B‬ CNY despite the estimated figure of ‪1.98 B‬ CNY. In the next quarter revenue is expected to reach ‪1.88 B‬ CNY.
Yes, you can track HANGZHOU TIGERMED financials in yearly and quarterly reports right on TradingView.
300347 stock has fallen by 9.40% compared to the previous week, the month change is a 0.52% fall, over the last year HANGZHOU TIGERMED has showed a 49.61% decrease.
300347 net income for the last quarter is ‪145.25 M‬ CNY, while the quarter before that showed ‪491.27 M‬ CNY of net income which accounts for −70.43% change. Track more HANGZHOU TIGERMED financial stats to get the full picture.
Today HANGZHOU TIGERMED has the market capitalization of ‪45.10 B‬, it has increased by 1.83% over the last week.
Yes, 300347 dividends are paid annually. The last dividend per share was 0.55 CNY. As of today, Dividend Yield (TTM)% is 1.04%. Tracking HANGZHOU TIGERMED dividends might help you take more informed decisions.
HANGZHOU TIGERMED dividend yield was 0.94% in 2023, and payout ratio reached 21.96%. The year before the numbers were 0.51% and 22.82% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 300347 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANGZHOU TIGERMED stock right from TradingView charts — choose your broker and connect to your account.
300347 reached its all-time high on Jul 1, 2021 with the price of 209.41 CNY, and its all-time low was 3.92 CNY and was reached on Aug 17, 2012.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANGZHOU TIGERMED technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANGZHOU TIGERMED stock shows the sell signal. See more of HANGZHOU TIGERMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on HANGZHOU TIGERMED future price: according to them, 300347 price has a max estimate of 82.80 CNY and a min estimate of 30.08 CNY. Read a more detailed HANGZHOU TIGERMED forecast: see what analysts think of HANGZHOU TIGERMED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANGZHOU TIGERMED EBITDA is ‪1.99 B‬ CNY, and current EBITDA margin is 27.57%. See more stats in HANGZHOU TIGERMED financial statements.